A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
Price : $35 *
At a glance
- Drugs Ropivacaine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 27 Jul 2018 Status changed from recruiting to completed.
- 23 Mar 2018 Planned End Date changed from 30 Nov 2017 to 30 Jun 2018.
- 23 Mar 2018 Planned primary completion date changed from 30 Nov 2017 to 30 Jun 2018.